A detailed history of Evergreen Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Evergreen Capital Management LLC holds 29,307 shares of NVO stock, worth $3.54 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
29,307
Previous 27,597 6.2%
Holding current value
$3.54 Million
Previous $3.54 Million 18.06%
% of portfolio
0.16%
Previous 0.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $209,834 - $251,216
1,710 Added 6.2%
29,307 $4.18 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $14,805 - $19,708
145 Added 0.53%
27,597 $3.54 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $27,475 - $33,005
-313 Reduced 1.13%
27,452 $2.84 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.28 Million - $2.81 Million
14,081 Added 102.9%
27,765 $2.52 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $43,986 - $48,687
282 Added 2.1%
13,684 $2.21 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $181,041 - $217,703
1,368 Added 11.37%
13,402 $2.13 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $32,200 - $42,493
-314 Reduced 2.54%
12,034 $1.63 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $38,016 - $46,655
399 Added 3.34%
12,348 $1.23 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $158,783 - $187,343
1,538 Added 14.77%
11,949 $1.33 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $62,097 - $75,064
667 Added 6.85%
10,411 $1.16 Million
Q4 2021

Mar 11, 2022

BUY
$95.88 - $117.08 $28,188 - $34,421
294 Added 3.11%
9,744 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $24,566 - $31,026
291 Added 3.18%
9,450 $907,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $36,468 - $45,685
539 Added 6.25%
9,159 $767,000
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $67,998 - $76,881
1,014 Added 13.33%
8,620 $581,000
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $35,139 - $40,590
550 Added 7.79%
7,606 $531,000
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $15,667 - $17,274
246 Added 3.61%
7,056 $490,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $93,195 - $108,160
-1,592 Reduced 18.95%
6,810 $446,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $39,023 - $51,111
-789 Reduced 8.58%
8,402 $506,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $5,384 - $6,292
-108 Reduced 1.16%
9,191 $532,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $110,102 - $123,743
2,316 Added 33.17%
9,299 $481,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $61,856 - $69,365
1,322 Added 23.35%
6,983 $356,000
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $34,120 - $38,735
-736 Reduced 11.51%
5,661 $296,000
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $4,860 - $5,528
117 Added 1.86%
6,397 $295,000
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $6,499 - $7,122
139 Added 2.26%
6,280 $296,000
Q2 2018

Aug 13, 2018

BUY
$44.29 - $50.42 $4,606 - $5,243
104 Added 1.72%
6,141 $283,000
Q1 2018

May 10, 2018

BUY
$48.49 - $58.14 $292,734 - $350,991
6,037 New
6,037 $297,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.